805 related articles for article (PubMed ID: 31607066)
1. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
[No Abstract] [Full Text] [Related]
2. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
Wang H; Feng L; Hu J; Xie C; Wang F
Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
Li J; Lu Q; Lu P
BMC Ophthalmol; 2018 Jun; 18(1):151. PubMed ID: 29940965
[TBL] [Abstract][Full Text] [Related]
5. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
[TBL] [Abstract][Full Text] [Related]
6. Increased Vitreous Chemerin Levels Are Associated with Proliferative Diabetic Retinopathy.
Li J; Hu WC; Song H; Lin JN; Tang X
Ophthalmologica; 2016; 236(2):61-6. PubMed ID: 27548269
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
[TBL] [Abstract][Full Text] [Related]
8. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy.
Velez G; Yang J; Li AS; Tsang SH; Bassuk AG; Mahajan VB
Sci Rep; 2019 May; 9(1):7608. PubMed ID: 31110225
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways.
Sen S; Udaya P; Jeya Maheshwari J; Kohli P; Parida H; Kannan NB; Ramasamy K; Dharmalingam K
Indian J Ophthalmol; 2023 Aug; 71(8):3069-3079. PubMed ID: 37530283
[TBL] [Abstract][Full Text] [Related]
10. Diabetes Induced Alterations in Murine Vitreous Proteome Are Mitigated by IL-6 Trans-Signaling Inhibition.
Robinson R; Youngblood H; Iyer H; Bloom J; Lee TJ; Chang L; Lukowski Z; Zhi W; Sharma A; Sharma S
Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):2. PubMed ID: 32870245
[TBL] [Abstract][Full Text] [Related]
11. The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease.
Schori C; Trachsel C; Grossmann J; Zygoula I; Barthelmes D; Grimm C
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD31-AMD40. PubMed ID: 30025106
[TBL] [Abstract][Full Text] [Related]
12. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina.
Nicoletti R; Venza I; Ceci G; Visalli M; Teti D; Reibaldi A
Br J Ophthalmol; 2003 Aug; 87(8):1038-42. PubMed ID: 12881351
[TBL] [Abstract][Full Text] [Related]
13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
14. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Suzuki Y; Yao T; Okumura K; Seko Y; Kitano S
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1519-1525. PubMed ID: 31062144
[TBL] [Abstract][Full Text] [Related]
15. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316
[TBL] [Abstract][Full Text] [Related]
16. Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after conbercept treatment.
Wang T; Chen H; Du X; Li N; Chen Y; Min H
J Proteomics; 2023 Mar; 276():104838. PubMed ID: 36764651
[TBL] [Abstract][Full Text] [Related]
17. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
[TBL] [Abstract][Full Text] [Related]
18. Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents.
Chen H; Qiu B; Gao G; Chen Y; Min H; Wu Z
Exp Eye Res; 2022 Mar; 216():108942. PubMed ID: 35032522
[TBL] [Abstract][Full Text] [Related]
19. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
20. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]